Table 2 Multivariable Cox regression analysis of the 24-lncRNA risk score, LNR and postoperative chemotherapy in GSE62254 series

24-lncRNA risk score (N = 300)

1.16

1.10 –1.21

<0.0001

LNR

4.33

1.34 –13.93

0.014

Age

1.03

1.00 –1.05

0.032

Gender

1.10

0.65 –1.84

0.732

TNM stage I

1.00(referent)

TNM stage II

1.08

0.23 –5.08

0.919

TNM stage III

2.09

0.47 –9.24

0.330

TNM stage IV

3.89

0.82 –18.44

0.087

24-lncRNA risk score (N = 299)

1.14

1.09 –1.19

< 0.0001

Postoperative chemotherapy

0.36

0.18 –0.73

0.004

Age

1.01

0.99 –1.03

0.324

Gender

1.04

0.62 –1.75

0.897

TNM stage I

1.00(referent)

TNM stage II

1.47

0.31 –6.85

0.626

TNM stage III

4.00

0.93 –17.15

0.062

TNM stage IV

8.50

2.00 –36.20

0.004